Class 3 Medicines Recall: Advanz Pharma, Carbimazole 10mg and 15mg tablets

Advanz Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling batches of carbimazole tablets due to an out of specification observation for tablet appearance of samples during routine stability testing.

Further information including details of the affected batches, a brief description of the problem and advice for healthcare professionals can be found on the MHRA website.